NovoCure Ltd. (NVCR)
14.94
-0.98
(-6.16%)
USD |
NASDAQ |
Oct 02, 16:00
14.94
0.00 (0.00%)
After-Hours: 20:00
NovoCure Cash from Operations (TTM) : -2.815M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.815M |
| March 31, 2026 | -26.88M |
| December 31, 2025 | -49.03M |
| September 30, 2025 | -34.48M |
| June 30, 2025 | -44.68M |
| March 31, 2025 | -30.46M |
| December 31, 2024 | -26.37M |
| September 30, 2024 | -37.48M |
| June 30, 2024 | -67.17M |
| March 31, 2024 | -88.18M |
| December 31, 2023 | -73.34M |
| September 30, 2023 | -62.48M |
| June 30, 2023 | -20.75M |
| March 31, 2023 | 17.75M |
| December 31, 2022 | 30.79M |
| September 30, 2022 | 48.90M |
| June 30, 2022 | 50.88M |
| March 31, 2022 | 61.29M |
| December 31, 2021 | 82.76M |
| September 30, 2021 | 121.83M |
| June 30, 2021 | 128.40M |
| March 31, 2021 | 114.97M |
| Date | Value |
|---|---|
| December 31, 2020 | 99.15M |
| September 30, 2020 | 52.63M |
| June 30, 2020 | 36.57M |
| March 31, 2020 | 32.89M |
| December 31, 2019 | 26.62M |
| September 30, 2019 | 36.47M |
| June 30, 2019 | 27.20M |
| March 31, 2019 | 10.64M |
| December 31, 2018 | -1.865M |
| September 30, 2018 | -21.58M |
| June 30, 2018 | -24.67M |
| March 31, 2018 | -23.05M |
| December 31, 2017 | -33.13M |
| September 30, 2017 | -43.96M |
| June 30, 2017 | -80.00M |
| March 31, 2017 | -103.52M |
| December 31, 2016 | -107.59M |
| September 30, 2016 | -119.99M |
| June 30, 2016 | -108.60M |
| March 31, 2016 | -102.40M |
| December 31, 2015 | -99.88M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Smith & Nephew plc | 1.330B |
| LivaNova Plc | 249.26M |
| Tristel Plc | 14.21M |
| EKF Diagnostics Holdings Plc | 11.08M |
| Niox Group Plc | 17.33M |